AJMANBANK

We are asked to evaluate AJMANBANK with the RISK lens. The RISK lens checks for concrete breaks: ocf_to_ni < 0.7, net_debt_to_ebitda > 4, ebitda_interest_cover < 2, liquidity.advv_30d_aed_m < 1, quarterly_gaps present, dividend cut evident. We must output BUY, HOLD, or SELL based on the number of breaks. First, gather the relevant figures from the pack. 1. ocf_to_ni: financial_statements.derived.ocf_to_ni = 3.67. That's > 0.7, so no break. (3.67 > 0.7) 2. net_debt_to_ebitda: We need to compute net debt and EBITDA. However, the pack does not provide an explicit net_debt_to_ebitda field. We'll have to derive it from available data. Net debt = total debt - cash. But we don't have cash directly. Total liabilities? Possibly we can approximate. The threshold is > 4. Let's see if we have enough data. Annual financial statements: total_liabilities = 29391.2 for 2025. But that includes all liabilities, not just debt. Debt might be a subset. Also, we don't have EBITDA. The fundamentals do not show EBITDA; we have operating_margin, net_margin. Could derive EBITDA from revenue and operating margin? operating_margin = 58.4061% (that's operating income / revenue?). Revenue = 898.6 million. So operating income ≈ 898.6 * 0.584061 = 524.8 million. But that might not be EBITDA; it might be operating profit. CFO is 1836 million, which is huge. Could EBITDA be approximated? Not enough. There's no explicit interest expense to compute EBIT/EBITDA. Probably we can't compute net_debt_to_ebitda accurately. The pack doesn't provide it. So we cannot assert a break based on this. The instruction says: "Score these concrete breaks, each only when the cited figure crosses its threshold". If we don't have the figure, we can't score it. So we ignore. 3. ebitda_interest_cover: Again, no explicit interest coverage ratio. We could try to compute: interest expense? Not provided. Operating profit? Net income? The bank is a financial institution, so these metrics may not apply straightforwardly. The pack might not have the data. So we cannot score this break. 4. liquidity.advv_30d_aed_m < 1: advv_30d_aed_m = 1.2181. That's > 1, so no break. 5. quarterly_gaps present: Are there quarterly gaps? The quarterly data shows periods: 2026-03-31, 2025-12-31 (derived), 2025-09-30, 2025-06-30, 2025-03-31, 2024-12-31 (derived). All consecutive. No gaps. So no break. 6. dividend cut evident in financial_statements: We need to check dividends paid history. Annual: 2025 dividends_paid = -197.5 (AED millions), 2024: not given dividends_paid? In annual, only 2025 has dividends_paid. But we have corporate_actions showing cash dividends: 2026 (9.18%), 2025 (7.25%), 2023 (3.5% bonus), 2019 (3.5%), 2018 (3.5%). So dividends have increased from 7.25% (2025) to 9.18% (2026) of? Not clear what percentage of face value? Usually cash dividends are a percentage of par value. Anyway, there's an increase, not a cut. So no break. Thus, 0 breaks. Per rules: 0 breaks -> your stance follows the evidence (BUY is legitimate if balance sheet clean and cash conversion strong). Here, ocf_to_ni is very strong (3.67), which means strong cash conversion. So BUY might be appropriate. But we must also weigh evidence for the stance. The RISK lens says: if 0 breaks, then stance follows the evidence. So we can output BUY. We also need to decide confidence. Confidence bands: 90-100 = multiple independent cited figures align AND a dated catalyst inside horizon; 70-89 = several aligned cited figures, no dated catalyst; 50-69 = clear evidence with real conflicts; 30-49 = mixed or one-sided; 10-29 = thin; below 40 output HOLD. Here, we have no breaks, strong cash conversion, and analyst strong_buy, some positive news (Sukuk issuance, dividend increase). Is there a dated catalyst inside the 4-week horizon? The horizon ends 2026-08-17. Today is 2026-07-20. Recent disclosures: Earnings Call on 2026-07-20 (today). That is a catalyst. Also, BOD meeting on 2026-07-13, etc. So there is a recent earnings call. But the pack shows last_results_filing.date = 2026-07-20, headline "Earnings Call". So that is today. So we have a catalyst within the horizon. However, we need multiple independent cited figures align. We can cite ocf_to_ni = 3.67, advv_30d_aed_m = 1.2181, no dividend cut. Also, the analyst target implies upside, etc. But for confidence, we need to see if there are multiple independent figures aligning. The figures we cite: ocf_to_ni is strong, liquidity is sufficient, no dividend cut. Analyst rec strong_buy. So confidence could be high. But the RISK lens specifically says: confidence 90-100 if multiple independent cited figures align AND a dated catalyst inside horizon. We have ocf_to_ni (3.67, far above 0.7), advv (1.2181 > 1), no dividend cut, no quarterly gaps. So at least 3 independent breaks are negative, so align on no breaks. The dated catalyst: today's earnings call. So we can assign 90-100. But note: we didn't find any breaks, so the evidence is clean. However, we have to see if there are any conflicts. The bank has high total liabilities to equity (8.46), but that's not a break per our defined set. So it doesn't count as a break. Also, debt_to_equity is 1.5047, which is high, but not in our thresholds. So no conflict from our lens. So I'd say confidence 92 or 95. But we need to be precise: we should pick a number. I'll pick 95 as it seems very clean. Now, point: one sentence citing a figure. The point should summarize the risk perspective. Something like: "No risk triggers breached: OCF/NI=3.67, ADV 1.22M, dividend increased, supporting a BUY." But it says "point": one sentence citing a figure. We'll cite a key figure. Risk: one line. Something like "Low risk with strong cash flow generation and ample liquidity." Stance: BUY. Target: For 4-week horizon, derive from pack evidence. The analyst target_mean is 1.8, which is 12-month. We should not restate that. We can try to derive a near-term target based on technicals? Or maybe we can use implied upside? But the horizon is 4 weeks. There's no specific target derivation method given. The instruction: "If you output a target, derive it from pack evidence for the 4-week horizon — do not restate analyst.target_mean (a 12-month figure) as your own target." So we might be able to set target as null, or derive something from recent price action? The technicals show ret_1m_pct = -1.4184, but positive 3m. No clear target. It's a short horizon; maybe we can use the analyst implied upside but scale it? The analyst.implied_upside_pct = 29.4964% over 12 months. For 4 weeks, very rough: (1.294964)^(4/52) -1 ≈ 2.0%? That would be 1.39 * 1.02 = 1.4178. That's one way. But not rigorous. Or we can say null. The pack doesn't offer a short-term target. So I'll output null. Citations: We need at least 2. We'll cite the fields that show no breaks: financial_statements.derived.ocf_to_ni, liquidity.advv_30d_aed_m, corporate_actions.history (to show dividend increase). Also maybe financial_statements.annual.0.dividends_paid to show no cut? But that's only one year. We can cite corporate_actions.history.0.details showing "9.18% cash dividends" and previous "7.25%", indicating increase. So citations: {"field":"financial_statements.derived.ocf_to_ni","value":3.67} {"field":"liquidity.advv_30d_aed_m","value":1.2181} {"field":"corporate_actions.history.0.details","value":"9.18% cash dividends"} {"field":"corporate_actions.history.1.details","value":"7.25% cash dividends"} We need to list exact paths. We'll output in citations array. Now construct JSON with keys: citations, point, risk, stance, confidence, target. We must ensure order: citations first, then point, risk, stance, confidence, target. Values: point: "Ajman Bank shows strong cash conversion with OCF/NI of 3.67 and no adverse risk triggers." risk: "No breaks cited; balance sheet cash generation is robust and liquidity exits are ample." stance: "BUY" confidence: 95 target: null Check: confidence 95 is within 90-100, justified by multiple alignments and a catalyst (earnings call today). Yes. Citations must use dotted paths exactly. We'll include a minimum of 2. I'll include the three breaks that are not tripped: ocf_to_ni, advv, and dividend info. For dividend, I'll use the most recent and previous to show no cut. Also, we could cite the quarterly data to show no gaps, but that's a negative check. So include: - financial_statements.derived.ocf_to_ni: 3.67 - liquidity.advv_30d_aed_m: 1.2181 - corporate_actions.history.0.details: "9.18% cash dividends" - corporate_actions.history.1.details: "7.25% cash dividends" - financial_statements.quarterly (show no gaps) but we don't need to prove no gaps; it's sufficient that we didn't cite any gap. But we could add a citation about quarterly coverage if we want. However, to keep it concise, 2-3 are enough. I'll use the first three. Now, produce JSON.

We are asked to output a JSON with a stance (BUY, HOLD, SELL) for AJMANBANK from the macro-liquidity lens. The macro-liquidity lens is cross-sectional: the peg and Fed rate are identical for all DFM names, so they cannot by themselves justify a stance on this one. A non-HOLD stance must cite which of this name's own figures makes it MORE or LESS exposed to the macro backdrop than the market. So we need to consider macro factors (fed funds rate, VIX, yield curve) and then select differentiating name-level figures: fundamentals.debt_to_equity (rate sensitivity), tv_technicals.beta_1y, liquidity.advv_30d_aed_m (flow sensitivity), sector, peer_context percentiles. We need to reason over the evidence pack, cite exact figures, and produce a stance covering the 4-week horizon ending 2026-08-17. First, look at macro conditions: fed_funds_rate = 3.63, vix = 16.73, yield_curve_2s10s_pct = 0.37 (positive but small). The yield curve is slightly positive, not inverted, which may be neutral to slightly positive for financials? But the macro backdrop: rates are at 3.63%, and the US 10y is 4.57%, so there's a gap. VIX 16.73 is relatively low, suggesting moderate risk appetite. However, the UAE peg means rates follow the Fed, so any rate movements affect all banks similarly. The differentiating factor for AJMANBANK is its debt_to_equity ratio: 1.5047. That is quite high for a bank? Actually, banks typically have high leverage, but this is debt_to_equity, which is total liabilities/equity? The annual liabilities_to_equity is 8.46 for 2025, but fundamentals.debt_to_equity is 1.5047. There's a discrepancy: fundamentals.debt_to_equity might be a different metric (possibly interest-bearing debt/equity). We should use the fundamentals.debt_to_equity as specified. That value of 1.5 indicates moderate leverage. Is that more or less than peers? Peer context shows median_pb: 1.35, and AJMANBANK pb is 1.0887, so it's slightly below median. But for debt/equity, we don't have a direct peer median. However, a debt_to_equity of 1.5 could be high relative to some banks? Actually, many banks have higher leverage. We need to argue whether this makes it more or less sensitive to rate changes. Typically, higher leverage means more sensitivity to interest rate changes. With the Fed funds rate at 3.63%, and the curve slightly positive, a higher leverage bank might benefit more from a steepening yield curve (since banks borrow short and lend long). But 1.5 is not extreme. Also, the sector is "Financial Services" which inherently has rate sensitivity. But we need to compare to market. Next, tv_technicals.beta_1y = 0.5644. That is below 1, indicating lower systematic risk than the market. So the stock is less sensitive to macro market moves (like VIX). So that might make it more defensive. But with VIX at 16.73 (low), a low beta stock might not be attractive if the market is risk-on; investors might prefer higher beta. But for a 4-week horizon, a low beta could provide stability, but not necessarily a BUY. Liquidity: advv_30d_aed_m = 1.2181 million AED. That is very low liquidity. That could be a risk factor: low liquidity makes it more sensitive to macro flows? Actually, low liquidity means it might be more volatile and subject to larger swings on any macro news, but also might indicate lack of interest. The macro-liquidity lens: low advv means it has high flow sensitivity, meaning small changes in macro-driven flows can cause large price moves. That could amplify both upside and downside. But we need a stance. Peer context: pe_percentile: 27 (lower P/E than 73% of peers, so relatively cheap), div_yield_percentile: 90 (higher dividend yield than 90% of peers, so attractive income). Dividend yield is 6.65%, which might be attractive in a moderate rate environment. But the payout ratio is 50.58%, so dividend seems sustainable. Consensus signal: analyst n=1, rec=strong_buy, target_mean=1.8, implying 29.5% upside. But we are to derive our own target for 4-week horizon. Not to restate analyst target. But the analyst view is positive. Catalysts: recent disclosure on 2026-07-20 is Earnings Call. That is today. So an earnings call happened. There might be information there. Also recent news: on 2026-07-14, listing of $300 million Additional Tier 1 Perpetual Sukuk. That is a capital raising event. It might strengthen capital, but also increase debt-like obligations. The profit rate is 6.5%, which is high, so could impact net income. But it also shows confidence. News on 2026-04-29: strong Q1 2026 results: net profit 130 million AED, revenue up 22% yoy. So recent fundamentals are strong. Now, the macro-liquidity lens: The Fed rate at 3.63% might be expected to stay or maybe cut? But we don't have a forecast. The yield curve at 0.37% suggests a slight steepening, which is positive for bank net interest margins. But all banks benefit. To differentiate AJMANBANK, we look at its debt_to_equity: 1.5047. If we compare to peers? The peer median pb is 1.35, but that's not directly debt. From the financial statements, annual liabilities_to_equity is 8.46 (2025), which is high but typical for banks. The fundamentals.debt_to_equity might be a different calculation. We'll use 1.5047. Is that high? We don't have peer debt_to_equity, but the pe_percentile 27 suggests it's cheaper, maybe because of higher leverage or risk. A lower P/E could mean the market prices in more risk, possibly from higher sensitivity to macro. So, if macro conditions improve, this stock might rise more. But the macro backdrop is mixed: VIX low, but there's some geopolitical news (Houthis naval embargo) which might increase risk. The UAE macro news includes Jaywan payment scheme launch, which could benefit banks. But that's sector-wide. Given the low beta (0.56), the stock is less sensitive to market moves. So if the market goes up, it might underperform; if down, it might outperform. For a 4-week horizon, with VIX low and possibly some uncertainties (Houthi news), a low beta might be safer, but a HOLD might be warranted unless we see a catalyst within the horizon. The horizon ends 2026-08-17. Do we have any dated catalysts within that window? The pack shows catalysts.results_filing_dates_24mo includes "2026-07-20" (today's earnings call). There's also "2026-05-11" and others past. No future dates within the 4-week horizon are given. So no specific dated catalyst inside the horizon. That means if we have aligned evidence but no dated catalyst, confidence would be in the 70-89 range (per instructions: "70-89 = several aligned cited figures, no dated catalyst"). Now, we need to decide stance. We must cite differentiating figures that make it more or less exposed to macro than the market. A BUY or SELL stance needs at least 2 citations. Let's consider: Bullish case: - Low beta (0.56) might be defensive, but not necessarily bullish in low VIX. - High dividend yield (6.65%, 90th percentile) could attract income seekers if rates are stable or falling? But fed funds at 3.63% and the 10y at 4.57% makes dividend yield slightly higher than those? Actually, dividend yield 6.65% is above the 10y, so that might be attractive. - Strong recent earnings: Q1 2026 net income 129.6M (quarterly), net margin 58.4%, revenue growth 11.5% yoy. So fundamentals are improving. - Analyst strong buy and EPS revisions upward (eps_rev_30d_pct +17.12%, eps_rev_90d_pct +4.91%). - Recent news of AT1 sukuk might improve capital and allow growth. Bearish case: - debt_to_equity 1.5047 might be high, making it vulnerable to rate increases. But rates are not high (3.63%) and curve is positive, so maybe not. - Low liquidity (advv 1.22M AED) could exacerbate any selling pressure. - The stock is underperforming over 12m (-1.9%) but recently 3m +6.9%. - RSI 48.28, so neutral. Given the macro-liquidity lens, the key is how macro affects this stock relative to others. A high debt_to_equity means higher sensitivity to rate changes. If the Fed rate is expected to stay stable or decline, that could be good for leveraged firms. But we have no specific rate forecast. The yield curve at 0.37% positive is slightly supportive for banks. The bank's own debt_to_equity of 1.5 is not excessively high, but without peer comparison, it's hard to say it's more sensitive. The beta of 0.56 suggests it's less sensitive to market moves, which might make it less exposed to macro volatility. So combined: moderately leveraged but low market beta. That could be a mixed signal. Given the evidence: strong fundamentals, positive analyst sentiment, and low beta might make it an attractive defensive pick. However, the low liquidity might be a concern. The macro backdrop: VIX 16.73 is low, which generally favors risk-taking, but a low beta stock won't benefit as much. So perhaps HOLD is most appropriate unless we can argue a macro shift that specifically benefits this name. The instructions: "A non-HOLD stance must cite which of this name's own figures makes it MORE or LESS exposed to the macro backdrop than the market." So if we choose BUY, we need to say it is less exposed (low beta) and thus a safe haven, but with low VIX, that might not drive outperformance. Or more exposed (high debt/equity) and thus benefits from positive yield curve, but beta says less market sensitivity. There's a conflict. Let's consider peer context: pe_percentile 27 (cheap), div_yield_percentile 90 (high). That could attract macro flows seeking yield in a low-rate environment? But rates are not that low. The yield curve is positive, so income stocks might be attractive. Possibly a BUY on the basis of dividend yield and low beta providing stability in an uncertain macro environment? But we need to cite at least 2 differentiating figures. We could cite debt_to_equity and beta. Or debt_to_equity and advv. I lean towards HOLD because: - Mixed signals: low beta suggests less sensitivity, so not a strong macro play. - Low liquidity: advv 1.22M AED means the stock is thinly traded, which could amplify moves but also poses exit risk. That might make it unsuitable for a macro trade. - No catalyst within the 4-week horizon. - RSI neutral. - Price is near MA200 (1.3715) and MA50 (1.4072), spot 1.39, so it's trading in between. Technicals tv_recommend_all -0.3121 (sell signal), but that's technical. From a macro-liquidity perspective, the stock's low beta and low liquidity suggest it may not track macro trends closely, making a macro-based stance difficult. So HOLD. But let's check if we can justify a BUY with confidence 70-89. If we say: high dividend yield makes it attractive relative to macro yields, and low beta provides defense, and debt/equity is moderate, that might be a BUY. But we need to cite exact figures for differentiating exposure. For example, "beta_1y of 0.56 indicates less exposure to macro volatility than the market, making it a defensive hold in a 16.73 VIX environment." That argues less exposed. But does that justify BUY? Not necessarily; it could be HOLD. To be BUY, we'd need to argue that less exposure is a reason to buy, which might be if macro outlook is uncertain. The macro outlook: VIX low, but there's geopolitical news (Houthi embargo) which could increase risk. So a defensive stock could be favored. But nothing in the pack says risk is increasing. The UAE macro news includes that, but it's about Saudi, not UAE directly. Maybe we can use the peer percentile: high dividend yield (90th percentile) combined with low beta makes it a bond-like proxy, attractive for income in a slightly positive yield curve environment. But we need to tie to macro backdrop: fed_funds_rate 3.63, us_10y 4.57, so dividend yield 6.65 is competitive. So investors seeking yield might rotate into this. That could justify BUY. But the instructions caution: "A non-HOLD stance must cite which of this name's own figures makes it MORE or LESS exposed to the macro backdrop than the market." So if we say high dividend yield makes it less exposed to rate mo

We are asked to act as SECTOR specialist for AJMANBANK (Ajman Bank PJSC) on the DFM. We need to provide a stance for 4-week horizon ending 2026-08-17, based on the evidence pack. The output must be JSON with keys: citations, point, risk, stance, confidence, target. First, understand the data: - Today: 2026-07-20, horizon ends 2026-08-17. - Spot price: 1.39 AED. - Analyst: n=1, rec=strong_buy, target_mean=1.8, eps_rev_30d_pct=17.12%, eps_rev_90d_pct=4.91%, implied upside 29.5%. - Fundamentals: PE TTM 7.6, PB 1.09, PS 4.34, ROE 15.76%, net margin 53.71%, rev growth yoy 17.97%, eps growth yoy 14.9%, debt/equity 1.5, current ratio 1.01, dividend yield 6.65%, payout ratio 50.58%. - Financial statements: annual data from 2021-2025. Latest annual 2025: revenue 898.6M, net income 500M, OCF 1836M, capex -58.6M, dividends paid -197.5M, equity 3472.3M, total assets 32863.5M, total liabilities 29391.2M, liabilities/equity 8.46, FCF 1777.4M, net margin 55.6%. Derived: rev CAGR 2y 2.4%, OCF/NI 3.67, div paid/FCF 0.11, ROE stmt 14.4%, FCF margin 197.8%. - Quarterly: Q1 2026 (period 2026-03-31): revenue 221.8M, net income 129.6M, margin 58.4%, revenue yoy 11.5%. Q4 2025 derived: rev 239M, NI 120M, margin 50.2%, yoy 98.7%. Q3 2025: rev 260.4M, NI 134.9M, margin 51.8%, yoy 38.7%. Q2 2025: rev 200.3M, NI 110.4M, margin 55.1%, yoy -14.1%. Q1 2025: rev 198.9M, NI 134.7M, margin 67.7%, yoy 2.1%. Q4 2024 derived: rev 120.3M, NI 111M, margin 92.3%, yoy -50.4%. - Recent disclosures: earnings call today (2026-07-20), press release 2026-07-08, BOD meeting 2026-07-13, Q1 2026 results in April, etc. - Recent news: Nasdaq Dubai listing $300M AT1 sukuk (July 14, 2026), Ajman Bank expands Dubai corporate banking presence (July 10), successful pricing of AT1 sukuk (July 8). Also Q1 2026 net profit before tax 134M, after tax 130M, total revenue up 22% yoy (from April 29 news). Dividend of 9.18 fils for 2025 paid. - Sector news: Bank of Sharjah Q2 2026 net profit jumps 39%, Gulf banks abandoning big bang overhauls, etc. - Macro: VIX 16.73, US yields slightly up, fed funds 3.63%, AED peg. - Technicals: RSI 48.28, price vs MA200 +1.35%, ret 1m -1.42%, ret 3m +6.92%, ret 12m -1.9%, relative strength vs DFMGI +1.74% over 3 months. TV recommend all -0.3121, MA -0.5333, other -0.0909. ADX 12.35 (low trend), CCI -63.26, stoch K 46.67, williams -40, rel volume 0.41. Beta 0.56. Max drawdown 1y -16.04%, 52-week range 1.28-1.66, current below 52w high by 16.27%. - Consensus signal drift: TV recommend all -0.4909, delta 5d +0.067, delta 10d +0.067, target mean delta 10d 0%, rec key change 10d: none -> strong_buy. So recently one analyst upgraded to strong buy? Actually, n=1, so it's just that one analyst. Target dispersion 0. - Peer context: median PE 11.32, PB 1.35, div yield 4.55. AJMANBANK PE 7.6 (percentile 27, lower than median), PB 1.09 (below median), div yield 6.65% (percentile 90, above median). So it's relatively cheap with high dividend. - Corporate actions: cash dividends history, latest 9.18% for 2025 ex-date 2026-03-12, so already paid. - Financial health: liabilities/equity 8.46, high leverage typical for banks. But ROE 15.76% solid. OCF strong, FCF strong. Dividend payout ratio ~50%, sustainable given FCF. Net margin high ~55% for a bank? Actually, net margin is likely net income/revenue (revenue probably total operating income). It's very high, indicating efficient operations. Now, as SECTOR specialist, focus on business economics, growth, margins, leverage, dividend durability. Ground in multi-year financial statement trends. Also weigh sector news. Multi-year trends: - Revenue: 2021: 676.3, 2022: 942.0, 2023: 857.5, 2024: 736.2, 2025: 898.6. Not a smooth growth; 2-year CAGR 2.4%. But 2025 revenue up 22% from 2024 (898.6 vs 736.2). So recent growth strong. - Net income: 2021: 116.2, 2022: 162.1, 2023: -390.4 (big loss), 2024: 400.6, 2025: 500.0. Turnaround story. 2023 loss due to maybe provisioning? Now profitable. - Net margin: 2021: 17.2%, 2022: 17.2%, 2023: -45.5%, 2024: 54.4%, 2025: 55.6%. So margin profile improved dramatically, now very high. - OCF: 2021: 2820.5, 2022: -1009.4, 2023: 782.4, 2024: 353.5, 2025: 1836.0. Volatile but 2025 strong. - FCF: 2021: 2802.4, 2022: -1039.5, 2023: 751.3, 2024: 319.4, 2025: 1777.4. Strong in 2025. - Equity: growing from 2515 in 2022 to 3472 in 2025. - Liabilities/equity: around 7-8 range, 2025: 8.46, high but stable for a bank. - Dividends paid: 2025: -197.5, 2024 probably? Not shown. But dividend yield 6.65% and payout 50.58%, so dividend well covered by earnings. FCF coverage: div paid 197.5, FCF 1777.4, so plenty of room. - ROE: derived ROE stmt 14.4%, fundamentals ROE 15.76% (TTM). Good. - Revenue growth yoy: 17.97% (TTM). EPS growth yoy: 14.9%. Positive. Quarterly trend: Q1 2026 revenue 221.8, up 11.5% yoy. Net margin 58.4%. The last three quarters show margins above 50%. So profitability is sustained. Sector news: Bank of Sharjah reported 39% net profit jump, reflecting strong banking sector. Other news about Gulf banks modernizing. Positive backdrop. Recent news specific to Ajman Bank: Successful $300M AT1 sukuk listing (July 2026), which strengthens capital. Also expanded corporate banking presence in Dubai. Q1 2026 results were strong: net profit before tax 134M, after tax 130M, total revenue up 22% yoy. That indicates continued growth. Catalyst: Earnings call today (2026-07-20). The horizon ends 2026-08-17, so this earnings call is within the horizon. Possibly it provides fresh guidance or tone. Since we cannot see the content, we must infer from other data. The headline is "Earnings Call" – likely Q2 2026 results? The last results filing was Q1 2026 (April 29). The next results would be for Q2 2026, which would be due around July-August. Today is July 20, and there is an earnings call on July 20. That is likely the Q2 2026 earnings call. So within the 4-week horizon, we have a major catalyst: Q2 2026 earnings release and call. Given recent trends, they likely continued the strong performance. Also, analyst EPS revisions up 17% in last 30 days, 4.9% in last 90 days, suggesting positive momentum. The single analyst has a strong buy and target 1.8, which is 29.5% upside. Technicals: RSI 48, neutral. Price near MA200 (+1.35%), recent pullback from highs? ret 1m -1.4%, ret 3m +6.9%, so short-term consolidation. Beta 0.56, low volatility. Relative strength slightly outperforming DFMGI (which is down). The technical recommendation from TV is negative (-0.31), but that's based on moving averages and indicators; ADX low, CCI negative but not extreme. Given the fundamentals, technical weakness might be an opportunity. Valuation: PE 7.6 vs peers median 11.32, so cheap. PB 1.09 vs median 1.35, cheap. Dividend yield 6.65% vs median 4.55, attractive. So the stock is undervalued relative to sector. Leverage: debt/equity 1.5 (fundamentals.debt_to_equity) and liabilities_to_equity 8.46, typical for bank. The AT1 sukuk issuance adds Tier 1 capital, improves capital adequacy, positive for growth and dividends. Dividend durability: payout 50.58% of earnings, FCF covers dividend many times over. Record of paying dividends (9.18% this year, 7.25% last year). So dividends seem secure. Risks: Geopolitical? Houthis naval embargo announcement against Saudi Arabia (uae_macro_news), could raise regional tensions, but UAE not directly targeted. Macro: VIX 16.73, market calm. US yields stable. No major immediate risks seen. The sector specialist risk could be: high leverage if asset quality deteriorates, but current profitability robust. Given the strong fundamentals, positive earnings revisions, upcoming catalyst (Q2 earnings call today), attractive valuation, I'd lean toward a BUY stance. Confidence: Since we have multiple independent cited figures aligning (e.g., revenue growth, margins, analyst revisions, valuation, dividend coverage) and a dated catalyst (earnings call today) inside the horizon, confidence should be high, 90-100 range. I'll set confidence to 95. Target: Derive from pack evidence for 4-week horizon. One way: if stock is undervalued, a re-rating toward peer median PE could give upside. Peer median PE is 11.32, our TTM PE 7.6. If it were to trade at, say, 9x TTM earnings (a more conservative re-rating given time frame), we could project. TTM EPS: Net income TTM can be derived from annual 2025 NI 500M, but we have quarterly data to compute TTM to latest quarter (Q1 2026). TTM net income = Q2 2025 to Q1 2026. From quarterly: Q2 2025: 110.4, Q3 2025: 134.9, Q4 2025: 120.0 (derived), Q1 2026: 129.6. Sum = 110.4+134.9+120+129.6 = 494.9 approx. Shares outstanding: market cap 3758395285 / share price 1.39 = 2,704,000,000 approx? Actually 3,758,395,285 / 1.39 = 2,703,881,500 shares. So TTM EPS = 494.9 / 2703.88 = 0.183 AED per share. At 9x PE, price target = 0.183*9 = 1.647, round to 1.65. Alternatively, using analyst target of 1.8 but that's 12-month, not 4-week. I could say target of 1.65 for the 4-week horizon, reflecting a modest re-rating as Q2 results confirm growth. Alternatively, if I think the catalyst will push it quickly, maybe higher. But I'll be conservative and derive from peer comparison or earnings growth. Since we have to derive from pack evidence, I'll use the TTM PE and assume a slight expansion. The stock is at 1.39, with a 1-year high of 1.66, so 1.65 is achievable. I'll set target = 1.65. Citations: Need at least 2 for non-HOLD. I'll cite: - fundamentals.pe_ttm: 7.6039 (low vs peer median 11.32) - analyst.eps_rev_30d_pct: 17.1233 (strong upward revision) - financial_statements.quarterly.0.revenue_yoy_pct: 11.5 (Q1 2026 yoy growth) - corporate_actions.history.0.details: "9.18% cash dividends" (dividend durability) - Also maybe fundamental.dividend_yield: 6.6522 vs peer median 4.55. But let's pick exact fields that support the case. The point should cite a figure. Risk: something like geopolitical tension or sector-specific risk. I'll structure: citations: array of objects with field and value. point: "Ajman Bank's net margin has improved to 55.6% in FY2025 from -45.5% in FY2023, with Q1 2026 revenue up 11.5% YoY, supporting a strong BUY stance." risk: "Geopolitical uncertainty from Houthi naval embargo or a potential rise in non-performing loans could pressure the stock." stance: "BUY" confidence: 95 target: 1.65 Make sure target is not just analyst target mean. Analyst target mean is 1.8, but that's 12-month. My derived target 1.65 is lower, for 4-week horizon. Now, ensure all fields are correct and order as specified: citations, point, risk, stance, confidence, target. Let's list citations more thoroughly: - {"field":"financial_statements.annual.0.net_margin_pct","value":55.6} for the margin improvement point. - {"field":"financial_statements.quarterly.0.revenue_yoy_pct","value":11.5} - {"field":"analyst.eps_rev_30d_pct","value":17.1233} to show upward revisions. - {"field":"fundamentals.pe_ttm","value":7.6039} and {"field":"peer_context.median_pe_ttm","value":11.32} comparison can be cited. But I need only 2 minimum, but I'll include multiple to show alignment. However, the instruction says "citations: list the exact pack fields your case rests on", so I should cite those that directly support the stance. I'll pick three. Output final JSON.

We are asked to output a JSON object with the TECHNICAL lens. We need to reason over the evidence pack and output a stance (BUY, HOLD, SELL), confidence, target (if any), point, risk, and citations. The horizon is 4 weeks ending 2026-08-17. We must focus on technicals: trend (MA50 vs MA200, price vs MA200), momentum, vol, drawdown/gap structure (indicators), rel-strength vs DFMGI. Also note corporate actions: upcoming ex-date? The corporate_actions.history has an ex_date for 2026-03-12, which is past, so no upcoming ex-date. So no mechanical drop to treat. Let's extract relevant technical indicators: - Price: spot = 1.39 - MA50: 1.4072 - MA200: 1.3715 - Price vs MA200: pct_vs_ma200 = 1.3477% (so slightly above) - Price vs MA50: spot < MA50? 1.39 < 1.4072, so price below MA50. - Trend: MA50 vs MA200: 1.4072 vs 1.3715, so MA50 above MA200, golden cross, bullish trend. - Momentum: RSI14 = 48.2842 (neutral, slightly below 50) - Volatility: realized_vol_annual_pct = 18.07%, ATR14_pct_of_price = 1.5416%, volatility_d = 2.2059% - Drawdown: max_drawdown_1y_pct = -16.0392% - Gap: largest_gap_3m_pct = 2.9197%, pct_no_trade_days_3m = 4.6875% (low) - Rel strength vs DFMGI: rel_strength_3m_vs_dfmgi_pct = 1.741% (outperforming slightly) - Returns: ret_1m_pct = -1.4184, ret_3m_pct = 6.9231, ret_12m_pct = -1.9032 - TV technicals: recommend_all = -0.3121 (bearish), recommend_ma = -0.5333 (strong sell on moving averages), recommend_other = -0.0909. ADX = 12.35 (weak trend), CCI20 = -63.26 (bearish), Stoch K = 46.67, Williams %R = -40.0 (neutral to bearish). Beta 1y = 0.5644 (low volatility relative to market). - 52-week high/low: high 1.66, low 1.28, current 1.39, pct_below_52w_high = 16.27%. - DFMGI context: dfmgi_ret_1m = -5.96%, 3m = -1.19%, pct_vs_MA200 = -3.55% (index below MA200). So overall market weak. Technical picture: Although MA50 > MA200 (bullish long-term trend), price is below MA50 and RSI is neutral-bearish. The TV technicals are bearish. Relative strength vs DFMGI is slightly positive. But overall, the stock has been in a range? ret_3m +6.9% but ret_1m -1.4%, so recent weakness. The max drawdown of -16% over 1 year suggests significant downside risk. Volume: rel_volume 0.4125 (below average). Given the 4-week horizon, the technical signals are mixed to slightly bearish. Confidence: no strong catalyst in the horizon, but there are recent news (Sukuk listing, expansion) but that's fundamental. Technically, we see bearish TV recommendation, price below MA50, weak momentum. However, price is above MA200, so long-term uptrend intact. But short-term might be consolidation or pullback. We need to cite exact figures. At least 2 citations for non-HOLD stance. If we go HOLD, confidence below 40? We can assess confidence: There's conflict: MA50>MA200 bullish, but price below MA50 and bearish oscillators. No dated catalyst within horizon (next results filing? The last was today 2026-07-20, next likely Q2 2026? But filings list shows recent: 2026-07-20 Earnings Call, so next might be Q3 2026? Not within 4 weeks). So no dated catalyst. Confidence likely 50-69 range due to conflicting signals. That could warrant HOLD if confidence below 40, but it says output HOLD below 40 confidence. However, we can still assign a stance and confidence. Since technicals are not clearly bullish, HOLD might be appropriate. But we need to see if there's enough for a directional stance. Given the bearish TV signals and short-term weakness, a SELL? But the fundamentals are strong (earnings growing, etc.) but we only look at technicals. We must stay pure technical. Let's evaluate: The stock is currently 1.39, MA50 1.4072, MA200 1.3715. So price is between the two, closer to MA200. RSI 48, not oversold. The trend is up (MA50>MA200), but price might be correcting towards MA200? It's only 1.35% above MA200. If it breaks below, it could be bearish. In the next 4 weeks, without a catalyst, the price might drift. The technical recommendation from TV is -0.3121 overall, which is bearish. So I'm leaning towards a HOLD with a cautious outlook. But we need to output stance: HOLD? Or BUY/SELL? The instructions say: "stance covers ONLY the 4-week horizon ... longer-term views belong in 'point', not the stance." So short-term: likely flat or slightly down. Given the mixed signals, HOLD seems safe. Confidence: We have conflicting evidence: bullish MA crossover vs bearish oscillators and price below MA50. No dated catalyst. So confidence in the 50-69 band? But wait, the confidence bands say: 50-69 = clear evidence with real conflicts. That fits. So confidence could be, say, 55. But we need to compute a precise number. Not round default, but we can pick a number within. I'll pick 55. Target: We may derive a target from technicals. For 4-week horizon, we might use something like the MA50 or recent resistance/support. But no clear target from the pack. Might be null. The instructions: "If you output a target, derive it from pack evidence for the 4-week horizon — do not restate analyst.target_mean." We could use MA50 as a potential resistance? Or MA200 as support? But not a precise target. I'll set target to null. Citations: Need to cite dotted paths with values. For technicals, we can cite indicators.ma50, indicators.ma200, indicators.pct_vs_ma200, indicators.rsi14, tv_technicals.tv_recommend_all, etc. At least 2 citations. Point: One sentence citing a figure. Example: "Price is 1.39, below the 50-day MA of 1.4072 but above the 200-day MA of 1.3715, with RSI neutral at 48.3." That captures the conflicting signals. Risk: One line. "A break below MA200 support at 1.3715 could accelerate selling pressure amid weak momentum." So output: { "citations": [ {"field": "indicators.ma50", "value": 1.4072}, {"field": "indicators.ma200", "value": 1.3715}, {"field": "indicators.rsi14", "value": 48.2842}, {"field": "tv_technicals.tv_recommend_all", "value": -0.3121} ], "point": "Price (1.39) is below MA50 (1.4072) but above MA200 (1.3715) with RSI neutral at 48.3, reflecting conflicting short- and long-term trends.", "risk": "A break below MA200 support at 1.3715 could accelerate selling pressure amid weak momentum.", "stance": "HOLD", "confidence": 55, "target": null } Confidence 55 fits the 50-69 range with real conflicts. Stance HOLD is appropriate as no clear direction.

We are the VALUATION lens. We need to assess AJMANBANK over a 4-week horizon ending 2026-08-17. Evidence pack as of today 2026-07-20. Key valuation metrics: multiples vs fair value, dividend support, analyst consensus with drift. We must cite exact figures. Let's extract relevant data: Fundamentals: - pe_ttm: 7.6039 - pb: 1.0887 - dividend_yield: 6.6522 - payout_ratio: 50.58 - roe: 15.7592 - net_margin: 53.7102 - rev_growth_yoy: 17.9662 - eps_growth_yoy: 14.8963 - debt_to_equity: 1.5047 - current_ratio: 1.0093 Financial statements derived: - div_paid_to_fcf: 0.11 (i.e., 11% of FCF paid as dividends, so strong coverage) - fcf_margin_pct: 197.8 (very high, due to large OCF relative to revenue; FCF = 1777.4 on rev 898.6, so 197.8% margin) - ocf_to_ni: 3.67 (strong cash conversion) - rev_cagr_2y_pct: 2.4 (low) - roe_stmt_pct: 14.4 Annual 2025: revenue 898.6, net_income 500.0, ocf 1836.0, capex -58.6, dividends_paid -197.5, fcf 1777.4, equity 3472.3, total_assets 32863.5, total_liabilities 29391.2, liabilities_to_equity 8.46. Quarterly: Q1 2026 revenue 221.8, net_income 129.6, net_margin 58.4, revenue yoy 11.5%. Peer context: median_pe_ttm 11.32, median_pb 1.35, median_div_yield 4.55. AJMANBANK pe_percentile 27 (cheaper than 73% of peers), div_yield_percentile 90 (higher yield than 90% of peers). So relatively undervalued on PE and high dividend. Analyst: n=1, rec strong_buy, target_mean 1.8 (implied upside 29.5%). Analyst estimates revisions: eps_rev_30d_pct 17.12% (strong upward revision), eps_rev_90d_pct 4.91%. rating_drift 0.0, net_up_30d 0. So one analyst, positive. Consensus signal drift: tv_recommend_all -0.4909 (bearish), but delta_5d and delta_10d both 0.067 (slight improvement). target_dispersion 0.0, target_mean_delta_10d_pct 0.0. rec_key_change_10d "none -> strong_buy" suggests a recent upgrade. Corporate actions: history shows 2026 cash dividends 9.18% (ex-date 2026-03-12), 2025 cash dividends 7.25%. So dividend yield based on recent dividends: 9.18% of face? Actually details say "9.18% cash dividends" and "7.25% cash dividends". Typically this is percentage of par value? But fundamentals.dividend_yield is 6.6522, which is likely based on last dividend and current price. Let's check: dividends declared 9.18%? Actually, from news: Ajman Bank to pay $68m in dividend for 2025, total dividend AED250 million, 9.18 fils per share. Current price 1.39 AED, so dividend yield = 0.0918 / 1.39 ≈ 6.6%, matches. So dividend is well-covered: payout ratio 50.58%, div_paid_to_fcf 0.11 (only 11% of free cash flow). So dividend looks sustainable. Technical indicators: rsi14 48.28 (neutral), pct_vs_ma200 1.3477 (slightly above), adx 12.35 (weak trend). tv_recommend_all -0.3121 (slightly bearish). Realized volatility 18.07% annual. Relative strength vs DFMGI 3m: +1.74%. Stock up 6.92% in 3m, down 1.42% in 1m. So no strong trend. Macro: stable, US yields moderate, VIX 16.73 moderate. Catalysts: recent filings: today is earnings call (2026-07-20), so Q2 results might have been released? Not clear. Last results filing date is 2026-07-20 earnings call. So we are right after an earnings call. Recent news: successful AT1 Sukuk issuance, expansion in Dubai. Positive. From valuation lens: multiples are low vs peers (PE 7.6 vs median 11.32), high dividend yield, strong cash flow. But there are risks: high liabilities_to_equity 8.46, debt_to_equity 1.5047, low current ratio 1.0. But for a bank, these are typical. The FCF margin is extremely high due to OCF boost? OCF 1836 vs net income 500 suggests non-cash charges or working capital changes. Might be volatile. The 2-year revenue CAGR only 2.4%, but recently growth picked up (rev_growth_yoy 17.97%). Analyst expects upside to 1.8, which is 29.5% above current 1.39. Over a 4-week horizon, can we expect convergence? Catalyst: today's earnings call might provide positive news. The analyst revision upward suggests improving sentiment. However, consensus signal drift overall is negative (-0.49), but the recent upgrade and positive EPS revisions align with strong fundamentals. Need to output stance: BUY/HOLD/SELL. Confidence bands: 90-100 if multiple independent cited figures align AND a dated catalyst inside horizon. We have a dated catalyst? Today is earnings call, which is a catalyst today, but the horizon is 4 weeks. The earnings call happened today, so its impact might be priced in over the next few days. Is there a specific dated catalyst inside the horizon? The pack doesn't mention any other dated events. So no clear dated catalyst after today. So confidence likely 70-89 if evidence aligns. Our evidence: low PE (7.6), high dividend yield (6.65%), sustainable dividend (div_paid_to_fcf 0.11), analyst target upside 29.5%, positive EPS revisions (+17% in 30d). But note: analyst target is 12-month, so not directly our horizon. Over 4 weeks, we can't expect full re-rating. But the stock might drift toward that target if market reacts to earnings. However, technicals are mixed, and valuation alone might not drive immediate price action. Risk: The bank has high leverage, and recent AT1 Sukuk issuance adds capital but also increased debt. Dividend yield high might indicate risk. Also, only one analyst. Point: "AJMANBANK trades at a PE of 7.6x (peer median 11.32x) and offers a 6.65% dividend yield, with dividends consuming just 11% of free cash flow." Risk: "Low liquidity and a single-analyst consensus limit conviction, while high leverage (liabilities/equity 8.46) could pressure the stock if credit conditions worsen." Stance: Given the cheap valuation and strong dividend support, with positive analyst revision, I'd lean BUY but with moderate confidence. However, the short horizon might not see much movement. I'll go BUY. Confidence: 70, because several aligned figures but no dated catalyst within horizon. Target: Derive a 4-week target from pack evidence. Analyst target 1.8 is 12-month, so not appropriate. We could use a simple re-rating if the stock moves toward peer multiple. But over 4 weeks, maybe just a modest bump. The stock is at 1.39. The ma50 is 1.4072, ma200 1.3715. So near moving averages. Possibly target 1.45? Not strong basis. Since no clear catalyst, output null target or a range? The instruction says: "if you output a target, derive it from pack evidence for the 4-week horizon". We could say no target, which is allowed with null. I'll set target: null, because no clear 4-week catalyst. But we can still have stance BUY. However, the format expects target as number or null. I'll output null. Citations: Need at least 2 for non-HOLD. I'll cite pe_ttm, peer median, dividend yield, div_paid_to_fcf, analyst target and revision. Exact format: { "citations": [ {"field": "fundamentals.pe_ttm", "value": 7.6039}, {"field": "peer_context.median_pe_ttm", "value": 11.32}, {"field": "fundamentals.dividend_yield", "value": 6.6522}, {"field": "financial_statements.derived.div_paid_to_fcf", "value": 0.11}, {"field": "analyst.target_mean", "value": 1.8}, {"field": "analyst.eps_rev_30d_pct", "value": 17.1233} ], "point": "AJMANBANK trades at 7.6x PE (peer median 11.3x) with a 6.65% dividend yield covered by only 11% of FCF.", "risk": "High leverage (liabilities/equity 8.46) and sole analyst coverage limit conviction.", "stance": "BUY", "confidence": 70, "target": null } Confidence: 70 fits the range for several aligned figures, no dated catalyst.